The Open for Thursday, Feb. 5, 2026

Key Concepts

• Canada announced a comprehensive automotive strategy focused on EV production and securing its position in a changing global market.
• Several major companies reported earnings, with mixed results impacting stock performance (Canada Goose, Barrick Mining, BCE, Alphabet, Palantir, Eli Lilly, NVIDIA).
• US markets showed weakness, particularly in the software sector, despite strong growth in Google Cloud.
• Increased capital expenditure by Alphabet signals a significant investment in AI infrastructure.
• Biotech sector “hot picks” were identified based on rare disease focus and promising clinical trial data.
• Consumer spending patterns are influenced by ordering methods (touchscreen kiosks vs. human interaction).

---

Market Overview & Company Performance (Initial Reports)

The trading day began with mixed market signals. BCE (Bell Canada Enterprises) reported operating revenue below expectations, though anticipates improvement through wireless pricing, product sales, and its AI segment. Canada Goose shares experienced a 16% decline following missed profit estimates and increased marketing costs, despite a 14% rise in direct-to-consumer revenue in North America and Asia. Barrick Mining exceeded profit and revenue estimates but saw a nearly 6% share decline due to concerns about 2026 production and free cash flow; the company plans to spin off its North American gold assets via an IPO, retaining significant control. The TSX was slightly down, with notable trading volume in Enbridge, a slip in Bank of Montreal, and gains for Celestica and Kinross Gold (though Kinross also experienced a decline of almost 4%).

US Market Performance & Key Stocks

US markets demonstrated weakness, particularly within the software industry. Berkshire Hathaway, Alphabet (Google’s parent company), and Tesla all saw declines (around 3%, 1%, and 2% respectively), while NVIDIA experienced a slight increase (1%). Palantir and Eli Lilly also posted losses (3% and 7% respectively). A $49 USD generic version of the weight loss drug Wegovy was announced by a company known for aggressive marketing tactics.

Canada’s New Automotive Strategy

Prime Minister Justin Trudeau and Industry Minister François-Philippe Champagne announced a new automotive strategy in Woodbridge, Ontario, emphasizing Canada’s commitment to the industry amidst US tariffs and the global shift to EVs. Canada’s automotive history dates back to 1867 with the Taylor Steam Buggy. The industry employs over half a million Canadians and is a core economic pillar.

The strategy includes: a $3 billion investment from the Strategic Response Fund and $100 million from the Regional Tariff Response Initiative; a “Productivity Super Deduction” reducing the marginal effective tax rate on investment to 13%; investment tax credits for clean electricity, clean technology manufacturing, and critical minerals; a reduced corporate tax rate for zero-emission technology manufacturers; doubling vehicle GHG standards stringency by 2035 (75% EV adoption, ultimately 90% by 2040) and repealing the Electric Vehicle Accessibility Standard (EVAS); a $2.3 billion program offering up to $5,000 for EV purchases (or $2,500 for plug-in hybrids), with incentives favouring Canadian-made vehicles and those from free trade partners; a $1.5 billion investment in a national charging infrastructure; a preference for a zero-tariff regime with the US, but exploration of a trade regime incentivizing Canadian production if US tariffs persist (potentially through tradable credits); diversification through the Defence Industrial Strategy; and establishing a full EV battery supply chain leveraging Canada’s clean energy network.

Alphabet’s Capital Expenditure & AI Investment

Dan Ives of Wedbush discussed Alphabet’s Q4 earnings, highlighting a planned near-doubling of CAPEX to approximately $180 billion by 2026, exceeding street expectations of $120 billion. This increased CAPEX is primarily directed towards AI infrastructure, specifically data centres. Google Cloud experienced 48% year-over-year revenue growth. While the market reacted negatively to the increased CAPEX, Ives argued it signals confidence in AI monetization.

Biotech Sector “Hot Picks”

Laura Chico of Wedbush identified three biotech “hot picks” focused on rare diseases: Viridian Therapeutics (Thyroid Eye Disease – TED, with a drug under review and a promising Phase 3 trial readout for Allegro BART); Edgewise Therapeutics (Hypertrophic Cardiomyopathy – HCM, with recent safety data alleviating concerns and Phase 2 data anticipated); and BioCryst (Hereditary Angioedema – HAE, with an oral treatment – Orladeyo – and a Phase 3 program for a long-acting injectable).

Final Market Check & Consumer Spending

The segment concluded with a final market check, noting continued downward pressure. Research indicated consumers tend to spend more when ordering from touchscreen kiosks in fast food restaurants, potentially due to reduced social pressure and enhanced product presentation.

---

Conclusion

The broadcast highlighted a dynamic market landscape shaped by economic indicators, company earnings, and strategic government initiatives. Canada’s ambitious automotive strategy signals a proactive approach to securing its future in the EV era. Significant investment in AI by companies like Alphabet underscores the growing importance of this technology, while the biotech sector presents potential opportunities in rare disease treatments. Overall, the day’s developments suggest a cautious but optimistic outlook, with ongoing monitoring of key economic factors and industry trends remaining crucial.